59 related articles for article (PubMed ID: 11120630)
1. Alpha-tocopherol succinate inhibits growth of gastric cancer cells in vitro.
Rose AT; McFadden DW
J Surg Res; 2001 Jan; 95(1):19-22. PubMed ID: 11120630
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor.
Yu A; Somasundar P; Balsubramaniam A; Rose AT; Vona-Davis L; McFadden DW
J Surg Res; 2002 Jun; 105(1):65-8. PubMed ID: 12069504
[TBL] [Abstract][Full Text] [Related]
3. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth.
Heisler T; Towfigh S; Simon N; Liu C; McFadden DW
J Surg Res; 2000 Jan; 88(1):23-5. PubMed ID: 10644462
[TBL] [Abstract][Full Text] [Related]
4. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest.
Li J; Tu HJ; Li J; Dai G; Dai YC; Wu Q; Shi QZ; Cao Q; Li ZJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):769-74. PubMed ID: 17700262
[TBL] [Abstract][Full Text] [Related]
5. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of indomethacin on growth and proliferation of gastric carcinoma cells KATO III.
Fujiwara Y; Tarnawski A; Fujiwara K; Arakawa T; Kobayashi K
J Physiol Pharmacol; 1993 Jun; 44(2):147-53. PubMed ID: 8358051
[TBL] [Abstract][Full Text] [Related]
7. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM
Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802
[TBL] [Abstract][Full Text] [Related]
9. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
Zhang M; Altuwaijri S; Yeh S
Oncogene; 2004 Apr; 23(17):3080-8. PubMed ID: 15048090
[TBL] [Abstract][Full Text] [Related]
10. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells.
Chang E; Ni J; Yin Y; Lin CC; Chang P; James NS; Chemler SR; Yeh S
Asian J Androl; 2007 Jan; 9(1):31-9. PubMed ID: 17187157
[TBL] [Abstract][Full Text] [Related]
11. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Zhang Q; Pan J; Zheng RL; Wang Q
Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
[TBL] [Abstract][Full Text] [Related]
12. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro.
Kline K; Cochran GS; Sanders BG
Nutr Cancer; 1990; 14(1):27-41. PubMed ID: 2367234
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
[TBL] [Abstract][Full Text] [Related]
14. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
Ni J; Pang ST; Yeh S
Prostate; 2007 Apr; 67(5):463-71. PubMed ID: 17252538
[TBL] [Abstract][Full Text] [Related]
15. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines.
Ramanathapuram LV; Hahn T; Graner MW; Katsanis E; Akporiaye ET
Cancer Immunol Immunother; 2006 Feb; 55(2):166-77. PubMed ID: 16041582
[TBL] [Abstract][Full Text] [Related]
16. Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells.
Elattar TM; Virji AS
Anticancer Res; 1999; 19(1A):365-8. PubMed ID: 10226568
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Weber T; Lu M; Andera L; Lahm H; Gellert N; Fariss MW; Korinek V; Sattler W; Ucker DS; Terman A; Schröder A; Erl W; Brunk UT; Coffey RJ; Weber C; Neuzil J
Clin Cancer Res; 2002 Mar; 8(3):863-9. PubMed ID: 11895920
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms.
Yu W; Jia L; Wang P; Lawson KA; Simmons-Menchaca M; Park SK; Sun L; Sanders BG; Kline K
Mol Nutr Food Res; 2008 Apr; 52(4):447-56. PubMed ID: 18381678
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
